INNOVATIVE TREATMENT APPROACHES IN ONCOLOGICAL DISEASES: IMMUNOTHERAPY AND GENETIC MODIFICATION
Abstract
This article analyzes innovative treatment approaches in oncological diseases: immunotherapy and genetic modification. While immunotherapy serves to destroy tumor cells by activating the patient's immune system, genetic modification allows for individualization of treatment at the molecular and genetic levels. Studies show the effectiveness, safety, and clinical significance of innovative strategies. The article highlights the future development prospects of innovative treatment methods and their role in oncological practice.
References
1. Mellman, I., Coukos, G., & Dranoff, G. (2011). Cancer immunotherapy comes of age. Nature, 480(7378), 480–489.
2. June, C. H., Sadelain, M. (2018). Chimeric antigen receptor therapy. New England Journal of Medicine, 379, 64–73.
3. Couzin-Frankel, J. (2013). Breakthrough of the year 2013: Cancer immunotherapy. Science, 342(6165), 1432–1433.
4. Morrison, C. (2016). Gene therapy: CRISPR in cancer treatment. Nature Reviews Clinical Oncology, 13, 9–10.
5. Ribas, A., & Wolchok, J. D. (2018). Cancer immunotherapy using checkpoint blockade. Science, 359(6382), 1350–1355.
6. Sadelain, M., Brentjens, R., & Riviere, I. (2013). The basic principles of chimeric antigen receptor design. Cancer Discovery, 3(4), 388–398.
7. Maus, M. V., & June, C. H. (2016). Making better chimeric antigen receptors for adoptive T-cell therapy. Clinical Cancer Research, 22(8), 1875–1884.
